PROGRESS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the sector of biopharmaceuticals, featuring promising breakthroughs throughout different health-related and industrial programs. With its structural similarity to Normally derived human serum albumin, OsrHSA provides a safer, more reputable substitute for therapeuti